A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation P Peretti-Watel, V Seror, S Cortaredona, O Launay, J Raude, P Verger, ... The Lancet infectious diseases 20 (7), 769-770, 2020 | 603 | 2020 |
The French public's attitudes to a future COVID-19 vaccine: The politicization of a public health issue JK Ward, C Alleaume, P Peretti-Watel, V Seror, S Cortaredona, O Launay, ... Social science & medicine 265, 113414, 2020 | 445 | 2020 |
Low acceptability of A/H1N1 pandemic vaccination in French adult population: did public health policy fuel public dissonance? M Schwarzinger, R Flicoteaux, S Cortarenoda, Y Obadia, JP Moatti PloS one 5 (4), e10199, 2010 | 310 | 2010 |
Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis JC Lagier, M Million, P Gautret, P Colson, S Cortaredona, ... Travel medicine and infectious disease 36, 101791, 2020 | 302 | 2020 |
Asymptomatic hypoxia in COVID-19 is associated with poor outcome P Brouqui, S Amrane, M Million, S Cortaredona, P Parola, JC Lagier, ... International Journal of Infectious Diseases 102, 233-238, 2021 | 146 | 2021 |
Vaccine hesitancy in the French population in 2016, and its association with vaccine uptake and perceived vaccine risk–benefit balance D Rey, L Fressard, S Cortaredona, A Bocquier, A Gautier, P Peretti-Watel, ... Eurosurveillance 23 (17), 17-00816, 2018 | 141 | 2018 |
The extra cost of comorbidity: multiple illnesses and the economic burden of non-communicable diseases S Cortaredona, B Ventelou BMC medicine 15, 1-11, 2017 | 119 | 2017 |
Long-term persistence of olfactory and gustatory disorders in COVID-19 patients NN Nguyen, JC Lagier, D Raoult, P Gautret Clinical microbiology and infection 27 (6), 931-932, 2021 | 87 | 2021 |
Beliefs and risk perceptions about COVID-19: evidence from two successive French representative surveys during lockdown AE Attema, O L’haridon, J Raude, V Seror, Coconel Group Frontiers in psychology 12, 619145, 2021 | 85 | 2021 |
Social differentiation of vaccine hesitancy among French parents and the mediating role of trust and commitment to health: a nationwide cross-sectional study A Bocquier, L Fressard, S Cortaredona, A Zaytseva, J Ward, A Gautier, ... Vaccine 36 (50), 7666-7673, 2018 | 81 | 2018 |
Small-area analysis of social inequalities in residential exposure to road traffic noise in Marseilles, France A Bocquier, S Cortaredona, C Boutin, A David, A Bigot, B Chaix, ... The European Journal of Public Health 23 (4), 540-546, 2013 | 76 | 2013 |
The labour market, psychosocial outcomes and health conditions in cancer survivors: protocol for a nationwide longitudinal survey 2 and 5 years after cancer diagnosis (the … AD Bouhnik, MK Bendiane, S Cortaredona, LS Teyssier, D Rey, ... BMJ open 5 (3), e005971, 2015 | 73 | 2015 |
General practitioners' choices and their determinants when starting treatment for major depression: a cross sectional, randomized case-vignette survey H Dumesnil, S Cortaredona, H Verdoux, R Sebbah, A Paraponaris, ... PLoS One 7 (12), e52429, 2012 | 62 | 2012 |
Is exposure to night-time traffic noise a risk factor for purchase of anxiolytic–hypnotic medication? A cohort study A Bocquier, S Cortaredona, C Boutin, A David, A Bigot, V Sciortino, ... The European Journal of Public Health 24 (2), 298-303, 2014 | 53 | 2014 |
Characteristics of patients and physicians correlated with regular influenza vaccination in patients treated for type 2 diabetes: a follow-up study from 2008 to 2011 in … P Verger, S Cortaredona, C Pulcini, L Casanova, P Peretti-Watel, ... Clinical Microbiology and Infection 21 (10), 930. e1-930. e9, 2015 | 50 | 2015 |
Antipsychotic prescribing in youths: a French community-based study from 2006 to 2013 H Verdoux, E Pambrun, S Cortaredona, M Tournier, P Verger European child & adolescent psychiatry 24, 1181-1191, 2015 | 47 | 2015 |
Clinical evidence of the role of Methanobrevibacter smithii in severe acute malnutrition A Camara, S Konate, M Tidjani Alou, A Kodio, AH Togo, S Cortaredona, ... Scientific reports 11 (1), 5426, 2021 | 43 | 2021 |
Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis AG Goubet, A Dubuisson, A Geraud, FX Danlos, S Terrisse, CAC Silva, ... Cell Death & Differentiation 28 (12), 3297-3315, 2021 | 41 | 2021 |
Early combination therapy with hydroxychloroquine and azithromycin reduces mortality in 10,429 COVID-19 outpatients M Million, JC Lagier, H Tissot-Dupont, I Ravaux, C Dhiver, C Tomei, ... Reviews in Cardiovascular Medicine 22 (3), 1063-1072, 2021 | 41 | 2021 |
Would we recover better sleep at the end of Covid-19? A relative improvement observed at the population level with the end of the lockdown in France F Beck, D Leger, S Cortaredona, P Verger, P Peretti-Watel, V Seror, ... Sleep medicine 78, 115-119, 2021 | 41 | 2021 |